Showing results (91-100 of 1,279) with videos related to

Sort By:
Pageof 128
BMC Nephrology|November 11, 2018
Early predictors of one-year mortality in patients over 65 presenting with ANCA-associated renal vasculitis: a retrospective, multicentre studyDimitri Titeca-Beauport, Alexis Francois, Thierry Lobbedez, et al.
Clinical Rheumatology|February 4, 2014
Risk factors for severe bacterial infections in patients with systemic autoimmune diseases receiving rituximabMarion Heusele, Pierre Clerson, Benoit Guery, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 11, 2019
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic SclerosisVincent Sobanski, Jonathan Giovannelli, Yannick Allanore, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 23, 2010
Comparison of the Farr radioimmunoassay, 3 commercial enzyme immunoassays and Crithidia luciliae immunofluorescence test for diagnosis and activity assessment of systemic lupus erythematosusDavid Launay, Jean Schmidt, Sébastien Lepers, et al.
Proteomics|October 19, 2021
Passages in culture and stimulation conditions influence protein expression of primary fibroblastsSolange Vivier, Aurélien Chepy, Fabrice Bray, et al.
Lupus|July 13, 2022
Dyslipidemia is insufficiently treated in antiphospholipid syndrome patientsCécile M Yelnik, Claire Martin, Emmanuel Ledoult, et al.
Frontiers in Immunology|November 23, 2018
Prevalence and Clinical Associations of Antiphospholipid Antibodies in Systemic Sclerosis: New Data From a French Cross-Sectional Study, Systematic Review, and Meta-AnalysisVincent Sobanski, Angélique Lemaire-Olivier, Jonathan Giovannelli, et al.
Autoimmunity Reviews|July 29, 2014
Serum free light chains of immunoglobulins as biomarkers for systemic sclerosis characteristics, activity and severityAurélia Lanteri, Vincent Sobanski, Carole Langlois, et al.
Arthritis Research & Therapy|March 6, 2021
18F-FDG positron emission tomography scanning in systemic sclerosis-associated interstitial lung disease: a pilot studyEmmanuel Ledoult, Maxime Morelle, Michael Soussan, et al.
Journal of Clinical Medicine|September 9, 2022
Association between Routine Laboratory Parameters and the Severity and Progression of Systemic SclerosisLiticia Chikhoune, Thierry Brousseau, Sandrine Morell-Dubois, et al.
Pageof 128